Cardax Inc Receivables Turnover Ratio (CDXI), from the first quarter 2021 to the first quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cardax Inc   (CDXI)
 

Cardax Inc Accounts Receivables Turnover Ratio from the first quarter 2021 to the first quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Cardax Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2021 to a ratio of 54.5, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2021. Average receivable collection period, for the Cardax Inc in Mar 31 2021 quarter, has decreased to 7 days, compared to 18 days, in the Dec 31 2020 quarter.

If we take a look into Healthcare sector 332 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2021 from 226 to 2438.

What is Receivable Turnover Ratio?
What is Cardax Inc Selling?


What is Receivable Turnover Ratio?





CDXI Receivables Turnover Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Receivable Change -64.52 % - - - -44.09 %
Y / Y Revenue Change -26.78 % -28.12 % -70.98 % 196.36 % -13.43 %
Receivable Turnover Ratio (TTM) 54.5 20.81 7.96 6.29 5.21
CDXI's Total Ranking # 2438 # 226 # 2045 # 2220 # 241
Accounts Receivable average collection period days 7 18 46 58 70
Seq. Receivable Change - - - - -49.66 %
Seq. Revenue Change -46.4 % 193.39 % -50.56 % -5.81 % -47.39 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 101
Healthcare Sector # 333
Overall Market # 2438

Receivable Turnover Ratio Statistics
High Average Low
0.79 0.42 0.29
(Dec 31 2018)   (Jun 30 2017)






Financial Statements
Cardax Inc 's Accounts Receivable $ 0 Millions Visit CDXI's Balance sheet
Cardax Inc 's Sales TTM $ 1 Millions Visit CDXI's Income Statement
Sources of CDXI's Revenues Visit CDXI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CDXI's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CDXI's Growth Rates CDXI's Roa CDXI's Inventory Turnover Ratio CDXI's Dividend Comparisons
CDXI's Profitability Ratios CDXI's Roi CDXI's Asset Turnover Ratio CDXI's Dividend Growth
CDXI's Valuation Ratios CDXI's Roe CDXI's Financial Strength Ratios CDXI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2021 Receivable at quarter ending Mar 31 2021
Prothena Corporation Public Limited Company  37.11 $ 0.872  Millions$ 0.024  Millions
Electromedical Technologies Inc   36.72 $ 0.690  Millions$ 0.019  Millions
Sangui Biotech International Inc  36.67 $ 0.059  Millions$ 0.002  Millions
Blueprint Medicines Corporation  36.35 $ 813.577  Millions$ 22.383  Millions
Lucira Health Inc   34.02 $ 4.516  Millions$ 0.133  Millions
Brookdale Senior Living Inc   33.58 $ 3,325.934  Millions$ 99.033  Millions
Concert Pharmaceuticals Inc   33.44 $ 7.900  Millions$ 0.236  Millions
National Vision Holdings Inc   31.42 $ 1,776.236  Millions$ 56.539  Millions
Arvinas Inc   29.26 $ 25.200  Millions$ 0.861  Millions
Advanced Container Technologies Inc   27.96 $ 3.544  Millions$ 0.127  Millions
Innovage Holding Corp   26.82 $ 610.955  Millions$ 22.776  Millions
Eargo Inc   26.32 $ 78.533  Millions$ 2.983  Millions
Pulmatrix Inc   25.87 $ 11.262  Millions$ 0.435  Millions
Fulcrum Therapeutics Inc   25.72 $ 12.862  Millions$ 0.500  Millions
Intellia Therapeutics Inc   25.24 $ 51.523  Millions$ 2.041  Millions
U S Physical Therapy Inc  24.02 $ 422.620  Millions$ 17.597  Millions
China Pharma Holdings Inc  23.51 $ 11.461  Millions$ 0.487  Millions
Revolution Medicines Inc   21.98 $ 41.568  Millions$ 1.891  Millions
Durect Corp  21.80 $ 29.548  Millions$ 1.356  Millions
Reflect Scientific Inc  21.64 $ 3.355  Millions$ 0.155  Millions
Harrow Inc   20.73 $ 52.497  Millions$ 2.532  Millions
Dariohealth Corp   20.42 $ 8.978  Millions$ 0.440  Millions
Scorpius Holdings inc   19.90 $ 2.585  Millions$ 0.130  Millions
Catalyst Pharmaceuticals Inc   19.84 $ 120.141  Millions$ 6.056  Millions
Avita Medical Inc   19.72 $ 22.805  Millions$ 1.156  Millions
Agape Atp Corporation  19.38 $ 3.754  Millions$ 0.194  Millions
Electrocore Inc   19.22 $ 3.966  Millions$ 0.206  Millions
Fonar Corporation  19.14 $ 77.378  Millions$ 4.043  Millions
Precigen Inc   18.91 $ 108.356  Millions$ 5.729  Millions
Histogen Inc   18.74 $ 2.993  Millions$ 0.160  Millions

Date modified: 2026-09-08T15:10:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.